0001209191-21-043041.txt : 20210624
0001209191-21-043041.hdr.sgml : 20210624
20210624164132
ACCESSION NUMBER: 0001209191-21-043041
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210622
FILED AS OF DATE: 20210624
DATE AS OF CHANGE: 20210624
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: HARRIGAN EDMUND
CENTRAL INDEX KEY: 0001177917
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-50768
FILM NUMBER: 211043372
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ACADIA PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001070494
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 061376651
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3611 VALLEY CENTRE DRIVE
STREET 2: SUITE 300
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
BUSINESS PHONE: 858-558-2871
MAIL ADDRESS:
STREET 1: 3611 VALLEY CENTRE DRIVE
STREET 2: SUITE 300
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-06-22
0
0001070494
ACADIA PHARMACEUTICALS INC
ACAD
0001177917
HARRIGAN EDMUND
C/O ACADIA PHARMACEUTICALS INC.
12830 EL CAMINO REAL, SUITE 400
SAN DIEGO
CA
92130
1
0
0
0
Director Stock Options (Right to Buy)
24.88
2021-06-22
4
A
0
11637
0.00
A
2031-06-21
Common Stock
11637
11637
D
Restricted Stock Units
2021-06-22
4
A
0
6391
0.00
A
Common Stock
6391
6391
D
The shares subject to the option shall vest quarterly over one year following the date of grant, with the final tranche vesting upon the earlier of one year following the date of grant or the next annual meeting date.
Each restricted stock unit represents a contingent right to receive one share of ACADIA common stock.
The restricted stock units shall vest in full upon the earlier of one year following the date of grant or the next annual meeting date.
/s/ Austin D. Kim, Attorney-in-Fact
2021-06-23